Clinical Trial

Mycophenolate After Stem Cell Transplant for Systemic Sclerosis

Study acronym: IMPACT-SSc
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A pilot single center randomized trial to test whether a full-scale RCT evaluating the role of post-AHSCT maintenance immunosuppression with MMF in preventing disease relapse is feasible . We are studying whether a brief course of treatment with MMF after AHSCT will serve to prevent disease relapse.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-08-08
Trial Details
NCT Number NCT07734012
Lead Sponsor Ottawa Hospital Research Institute
Collaborators: The Ottawa Hospital Academic Medical Organization (TOHAMO) Innovation Fund Grant.
Conditions Systemic Sclerosis (SSc)
Enrollment 6 participants
Start Date 2026-08
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-07